Cannabinoid · Phytocannabinoid
Cannabidiphorol (CBDP) is a phytocannabinoid made by the cannabis plant, in the CBD-type group. 7-carbon CBD analog found alongside THCP in 2019.
Where it fits
Cannabidiphorol (CBDP) sits in the CBD-type group. See the Phytocannabinoids index for how it relates to the rest of the family.
What the research shows
Direct human research on Cannabidiphorol (CBDP) is minimal; it is characterised mainly by its chemistry and its place in the cannabinoid family rather than by clinical studies. We flag that plainly rather than overstate it.
FAQ
Is CBDP intoxicating? No. Cannabidiphorol (CBDP) is non-intoxicating.
How does CBDP differ chemically from CBD? CBDP carries a 7-carbon heptyl side chain (C23H34O2) on its resorcinol ring instead of the 5-carbon pentyl chain of CBD (C21H30O2).
When was CBDP discovered in cannabis? CBDP was first isolated and characterized in 2019 by Citti et al. from the Italian medicinal Cannabis sativa strain FM2 using UHPLC-HRMS and NMR.
Heptyl Side Chain (C7H15) Isolation, Biosynthesis from CBGP, and Receptor Profile
Cannabidiphorol (CBDP, C23H34O2) is the 7-carbon heptyl-side-chain homolog of cannabidiol (CBD), isolated and characterized by UHPLC-HRMS and NMR from the Italian medicinal Cannabis sativa variety FM2 alongside delta-9-THCP (Citti et al., 2019, PubMed PMID 31889124). In the plant, CBDP originates from cannabigerophorolic acid (CBGPA) via CBDAS-mediated cyclization to cannabidiphorolic acid (CBDPA), which decarboxylates to neutral CBDP upon heating as outlined in the decarboxylation temperature chart (Linciano et al., 2020, PubMed PMID 31891265). Unlike its psychotropic isomer THCP, CBDP shares the open resorcinol ring geometry of CBD and does not act as an intoxicating CB1 receptor agonist (Citti et al., 2019, PubMed PMID 31889124).
Part of the NOIDS cannabinoids index. Educational reference, not medical advice.